Jack Allen 's Stock Ratings

Baird Analyst

Jack Allen is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025

Overall Average Return

-19.2%

Smart Score

36.8%

Overall Average Return Percentile

13th

Number of Ratings

48
Buy NowGet Alert
12/12/2024CARMBuy Now
CARISMA Therapeutics
$0.40152.59%
Jack Allen 36%
$10 → $1DowngradeOutperform → NeutralGet Alert
11/15/2024INKTBuy Now
MiNK Therapeutics
$7.74-48.32%
Jack Allen 36%
$80 → $40MaintainsOutperformGet Alert
11/08/2024VORBuy Now
Vor Biopharma
$0.831591.84%
Jack Allen 36%
$22 → $14MaintainsOutperformGet Alert
11/06/2024ACLXBuy Now
Arcellx
$71.3748.52%
Jack Allen 36%
$77 → $106MaintainsOutperformGet Alert
10/25/2024NTLABuy Now
Intellia Therapeutics
$8.71106.78%
Jack Allen 36%
$24 → $18MaintainsNeutralGet Alert
09/16/2024TILBuy Now
Instil Bio
$18.38879.33%
Jack Allen 36%
$180 → $180ReiteratesOutperform → OutperformGet Alert
09/13/2024TILBuy Now
Instil Bio
$18.38879.33%
Jack Allen 36%
$32 → $180MaintainsOutperformGet Alert
08/15/2024BLUEBuy Now
bluebird bio
$3.8456.25%
Jack Allen 36%
$140 → $120MaintainsOutperformGet Alert
06/13/2024MREOBuy Now
Mereo BioPharma Group
$2.43229.22%
Jack Allen 36%
→ $8Initiates → OutperformGet Alert
05/13/2024TILBuy Now
Instil Bio
$18.3874.1%
Jack Allen 36%
$54 → $32MaintainsOutperformGet Alert
05/09/2024CRSPBuy Now
CRISPR Therapeutics
$40.9526.98%
Jack Allen 36%
$46 → $52MaintainsNeutralGet Alert
02/29/2024ACLXBuy Now
Arcellx
$71.377.89%
Jack Allen 36%
$63 → $77MaintainsOutperformGet Alert
01/19/2024TILBuy Now
Instil Bio
$18.38193.8%
Jack Allen 36%
→ $54ReiteratesOutperform → OutperformGet Alert
01/17/2024TILBuy Now
Instil Bio
$18.38193.8%
Jack Allen 36%
$100 → $54MaintainsOutperformGet Alert
12/12/2023BLUEBuy Now
bluebird bio
$3.8482.29%
Jack Allen 36%
$200 → $140MaintainsOutperformGet Alert
10/31/2023IMCRBuy Now
Immunocore Hldgs
$29.26187.08%
Jack Allen 36%
→ $84Initiates → OutperformGet Alert
09/26/2023FREQBuy Now
Frequency Therapeutics
——
Jack Allen 36%
$200 → $25DowngradeOutperform → NeutralGet Alert
08/15/2023ACLXBuy Now
Arcellx
$71.37-27.14%
Jack Allen 36%
$40 → $52MaintainsOutperformGet Alert
08/15/2023TSHABuy Now
Taysha Gene Therapies
$1.59403.14%
Jack Allen 36%
$6 → $8MaintainsOutperformGet Alert
08/10/2023DBTXBuy Now
Decibel Therapeutics
——
Jack Allen 36%
$21 → $5.25DowngradeOutperform → NeutralGet Alert
06/28/2023CARMBuy Now
CARISMA Therapeutics
$0.402425.89%
Jack Allen 36%
→ $10ReiteratesOutperform → OutperformGet Alert
04/14/2023ACLXBuy Now
Arcellx
$71.37-45.36%
Jack Allen 36%
→ $39Initiates → OutperformGet Alert
04/14/2023CARMBuy Now
CARISMA Therapeutics
$0.402425.89%
Jack Allen 36%
→ $10Initiates → OutperformGet Alert
04/13/2023ACLXBuy Now
Arcellx
$71.37-45.36%
Jack Allen 36%
→ $39Initiates → OutperformGet Alert
03/24/2023VORBuy Now
Vor Biopharma
$0.832558.61%
Jack Allen 36%
$38 → $22MaintainsOutperformGet Alert
03/07/2023CRSPBuy Now
CRISPR Therapeutics
$40.9512.33%
Jack Allen 36%
→ $46Initiates → NeutralGet Alert
03/07/2023BLUEBuy Now
bluebird bio
$3.84160.42%
Jack Allen 36%
→ $200Initiates → OutperformGet Alert
02/24/2023NTLABuy Now
Intellia Therapeutics
$8.71382.48%
Jack Allen 36%
$58 → $42MaintainsNeutralGet Alert
02/14/2023FREQBuy Now
Frequency Therapeutics
——
Jack Allen 36%
$500 → $200MaintainsOutperformGet Alert
02/01/2023TSHABuy Now
Taysha Gene Therapies
$1.59277.36%
Jack Allen 36%
$10 → $6MaintainsOutperformGet Alert
01/06/2023ALLOBuy Now
Allogene Therapeutics
$1.70605.88%
Jack Allen 36%
→ $12UpgradeNeutral → OutperformGet Alert
11/17/2022TILBuy Now
Instil Bio
$18.38-23.83%
Jack Allen 36%
$480 → $280MaintainsOutperformGet Alert
11/02/2022LCTXBuy Now
Lineage Cell Therapeutics
$0.53843.04%
Jack Allen 36%
→ $5Initiates → OutperformGet Alert
11/02/2022FREQBuy Now
Frequency Therapeutics
——
Jack Allen 36%
→ $500Initiates → OutperformGet Alert
11/01/2022TILBuy Now
Instil Bio
$18.3830.58%
Jack Allen 36%
$620 → $480MaintainsOutperformGet Alert
10/26/2022TSHABuy Now
Taysha Gene Therapies
$1.591220.75%
Jack Allen 36%
$26 → $21MaintainsOutperformGet Alert
09/13/2022RCORBuy Now
Renovacor
——
Jack Allen 36%
→ $9Initiates → OutperformGet Alert
09/06/2022TILBuy Now
Instil Bio
$18.3868.66%
Jack Allen 36%
$680 → $620MaintainsOutperformGet Alert
06/03/2022FATEBuy Now
Fate Therapeutics
$0.903005.42%
Jack Allen 36%
→ $28Initiates → NeutralGet Alert
06/03/2022ALLOBuy Now
Allogene Therapeutics
$1.70547.06%
Jack Allen 36%
→ $11Initiates → NeutralGet Alert
05/18/2022CLLSBuy Now
Cellectis
$1.31—
Jack Allen 36%
—UpgradeNeutral → OutperformGet Alert
03/09/2022TSHABuy Now
Taysha Gene Therapies
$1.591535.22%
Jack Allen 36%
→ $26Initiates → OutperformGet Alert
12/03/2021VORBuy Now
Vor Biopharma
$0.834492.15%
Jack Allen 36%
→ $38Initiates → OutperformGet Alert
11/09/2021INKTBuy Now
MiNK Therapeutics
$7.74235.92%
Jack Allen 36%
→ $260Initiates → OutperformGet Alert
10/22/2021DBTXBuy Now
Decibel Therapeutics
——
Jack Allen 36%
→ $21Initiates → OutperformGet Alert
10/08/2021CLLSBuy Now
Cellectis
$1.31663.36%
Jack Allen 36%
$39 → $10DowngradeOutperform → NeutralGet Alert
10/07/2021VYGRBuy Now
Voyager Therapeutics
$3.72141.94%
Jack Allen 36%
$6 → $9UpgradeNeutral → OutperformGet Alert
08/13/2021TILBuy Now
Instil Bio
$18.3884.98%
Jack Allen 36%
→ $680Initiates → OutperformGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free